Popular Articles

Rampant Disease Osteoporosis: Under-diagnosed, Under-treated - Experts Call For Earlier Diagnosis And Therapy
"With a continuously ageing population the incidence of osteoporosis is steadily rising. This does not only pose problems to the individuals concerned but is also an enormous challenge for our societies" according to Professor Wolfhart Puhl, past president of the European Federation of National Associations of Orthopaedics and Traumatology (EFORT). Prof. Puhl, of the Orthopç¤dikum Allgç¤u, Germany, who is in Vienna for the EFORT Congress, emphasized that the problem"s "dimension is frequently underestimated. Policy makers and funding agencies do not always consider this development sufficiently in their planning."

Children's Hospitals And Clinics Of Minnesota Receive Level III Trauma Designation
The Minnesota Department of Health recently designated Children"s Hospitals and Clinics of Minnesota"s two hospital locations as Level III Trauma Hospitals. Children"s of Minnesota has the sixth busiest pediatric emergency department in the nation with over 84,000 visits per year, and already treats around 450 trauma cases each year. Children"s voluntarily participated in the intense designation process, which included an external review of the hospitals" res and capabilities to care for young trauma patients. Children"s met the required standards of commitment, clinical and equipment res, and staff training.
News of the day
Most Parents Support Using Newborn Screening Data For Research
More than three-quarters of parents would be willing to permit the use of their children"s newborn screening samples for research purposes if their permission were obtained beforehand, a University of Michigan survey shows.
Sexual Health

Evidence Of Harm Has Been Linked To Various Vaccines Challenging Prevailing Public Recommendations

Researchers at the Mayo Clinic set out to determine whether the flu vaccine was effective in reducing the number of hospitalizations for all children, and especially the ones with asthma. The study involved 263 children who were evaluated from six months to 18 years of age, each of whom had had laboratory-confirmed influenza between 1996 to 2006. The investigators determined which children had and had not received the flu vaccine, their asthma status, and who did and did not require hospitalization. Records were reviewed for each subject with influenza-related illness, for flu vaccination preceding the illness, and hospitalization during that illness. "They found that children who had received the flu vaccine had three times the risk of hospitalization, as compared to children who had not received the vaccine. In asthmatic children, there was a significantly higher risk of hospitalization in subjects who received the TIV, as compared to those who did not (p= 0.006)." So, will these disturbing findings--namely, ineffectiveness of the TIV vaccine coupled with evidence of harm--lead the Center for Disease Control and the American Academy of Pediatrics (AAP) to rescind their recommendation for annual influenza vaccination for all children aged six months to 18 years? Or will our public health policy continue to be guided by the entrenched pharmaceutical industry? When evidence suggests that current vaccine recommendations are harming children it is unethical to delay issuing a cautionary advisory by invoking "more studies are needed" to delay action. Public health policy should be guided by the precautionary principle--"Above all, do no harm"--not by business interests. American Thoracic Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):